- Home
- PNC vs BMY Comparison
PNC vs BMY Comparison
Compare PNC & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNC | BMY |
|---|---|---|
| Founded | 1852 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9B | 123.7B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PNC | BMY |
|---|---|---|
| Price | $205.45 | $59.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 15 |
| Target Price | ★ $232.00 | $61.93 |
| AVG Volume (30 Days) | 2.2M | ★ 10.0M |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | 3.29% | ★ 4.19% |
| EPS Growth | ★ 20.74 | N/A |
| EPS | ★ 16.59 | N/A |
| Revenue | ★ $23,099,000,000.00 | N/A |
| Revenue This Year | $16.52 | N/A |
| Revenue Next Year | $4.62 | N/A |
| P/E Ratio | ★ $12.45 | $17.26 |
| Revenue Growth | ★ 7.16 | N/A |
| 52 Week Low | $148.28 | $42.52 |
| 52 Week High | $243.94 | $62.89 |
Technical Indicators
Market Signals| Indicator | PNC | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 34.45 | 49.83 |
| Support Level | $198.68 | $59.23 |
| Resistance Level | $210.75 | $62.47 |
| Average True Range (ATR) | 6.09 | 1.14 |
| MACD | -2.15 | -0.40 |
| Stochastic Oscillator | 18.37 | 14.93 |
Price Performance
Historical ComparisonAbout PNC PNC Financial Services Group Inc. (The)
PNC Financial is one of the three super-regional banks in the US, with around $560 billion in total assets at the end of June 30, 2025. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 37% of revenue from fee income and 63% from net interest income in 2024.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.